(Q52870855)

English

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.

scientific article published in January 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

elevated plus maze

1 reference

based on heuristic

inferred from title

author name string

R J Rodgers

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

N J Johnson

2

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

S J Norton

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

J C Cole

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

language of work or name

0 references

publication date

1 January 1995

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

Journal of Psychopharmacology

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

9

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

38-42

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

1

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Actions of buspirone in a putative model of anxiety in the mouse.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Effects of amperozide in two animal models of anxiety

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Recent developments in 5HT-related pharmacology of animal models of anxiety.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

The anxiety/defense test battery: influence of gender and ritanserin treatment on antipredator defensive behavior

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

1 reference

https://api.crossref.org/works/10.1177%2F026988119500900107

21 January 2018

Identifiers

10.1177/026988119500900107

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/22298692

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52870855&oldid=1239956319"